Lung Cancer News

Week Ending April 5, 2021 Pfizer’s Vizimpro is among 3 FDA-approved drugs that combat COVID-19 in lung cells: report“Ever since the COVID-19 pandemic was declared over a year ago, researchers around the world have been searching for existing drugs that might be...

Hepatitis C News

Week Ending April 5, 2021 Infected blood victim tells of impact of living with hepatitis C “A 45-year-old Co Down man has told how his marriage broke down due to the strain of living with hepatitis C which he contracted from infected blood. Martin Sloan, who has...

My Choices News

Week Ending April 5, 2021 Easing Breathlessness in Patients With Advanced Cancer“Along with fatigue and depression, dyspnea is a common symptom that affects many patients with cancer.1 But while common, breathlessness can be both debilitating and very distressing for...

Lung Cancer News

Week Ending March 29, 2021 NCCN Updates Clinical Practice Guideline for Small Cell Lung Cancer “On March 23, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for small cell lung cancer.” Targeted therapies...

My Choices News

Week Ending March 29, 2021 National Nutrition Month: Healthy eating guidelines“National Nutrition Month is an educational campaign created by the Academy of Nutrition and Dietetics. During the month of March, individuals are encouraged to make informed food choices...

Hepatitis C News

Week Ending March 29, 2021 DAA Therapy Promising for Geriatric Hepatitis C Patients “Oral antiviral therapy could increase treatment tolerability and response in geriatric patients with chronic hepatitis C virus (HCV) infections.” COVID Vaccine Side Effects and...